Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: A rare case of ALK-KIF5B gene fusion benefited from treatment with lorlatinib. | Front Oncol | 2025 | 40852483 | PubTator, text mining | PubMed |
| Defective autophagy in vascular smooth muscle cells promote uremic accelerated atherosclerosis. | Ren Fail | 2025 | 40804030 | PubTator, text mining | PubMed |
| Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia. | Nat Commun | 2025 | 40750773 | PubTator, text mining | PubMed |
| Applications of multiplexed CRISPR-Cas for genome engineering. | Exp Mol Med | 2025 | 40745004 | PubTator, text mining | PubMed |
| Comprehensive identification of NRG1 fusions in 25,203 patients with solid tumors. | NPJ Precis Oncol | 2025 | 40730881 | PubTator, text mining | PubMed |
| Exploring Autophagy-Related Gene Expression in Hepatocellular Carcinoma via TCGA, GEPIA2, and HPA Databases: Implications for Prognosis. | J Hepatocell Carcinoma | 2025 | 40726620 | PubTator, text mining | PubMed |
| Case Report: Successful late-line pralsetinib treatment in an ALK-rearranged lung adenocarcinoma patient with KIF5B-RET fusion resistant to alectinib. | Front Genet | 2025 | 40599544 | PubTator, text mining | PubMed |
| Oxyresveratrol suppressed melanogenesis, dendrite formation, and melanosome transport in melanocytes via regulation of the MC1R/cAMP/MITF pathway. | Sci Rep | 2025 | 40594379 | PubTator, text mining | PubMed |
| The Genomic Landscape of Romanian Non-Small Cell Lung Cancer Patients: The Insights from Routine NGS Testing with the Oncomine Dx Target Panel at the PATHOS Molecular Pathology Laboratory. | Cancers (Basel) | 2025 | 40563596 | PubTator, text mining | PubMed |
| Correction: LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis. | Oncol Res | 2025 | 40486883 | PubTator, text mining | PubMed |
| Dominant spinal muscular atrophy linked mutations in the cargo binding domain of BICD2 result in altered interactomes and dynein hyperactivity. | bioRxiv | 2025 | 40462900 | PubTator, text mining | PubMed |
| Decoding the role of microtubules: a trafficking road for vesicle. | Theranostics | 2025 | 40303338 | PubTator, text mining | PubMed |
| Krüppel-like factors in mitochondrial quality control. | Front Physiol | 2025 | 40265156 | PubTator, text mining | PubMed |
| Migrasomes as intercellular messengers: potential in the pathological mechanism, diagnosis and treatment of clinical diseases. | J Nanobiotechnology | 2025 | 40254563 | PubTator, text mining | PubMed |
| Molecular basis identification and hypnotic drug interactions for cognitive impairment related to sleep deprivation. | BMC Psychiatry | 2025 | 40229714 | PubTator, text mining | PubMed |
| The cohesin-associated protein Pds5A governs the meiotic spindle assembly via deubiquitination of Kif5B in oocytes. | Sci Adv | 2025 | 40215310 | PubTator, text mining | PubMed |
| The fusion characteristics of RET fusion in pan-cancer among the Chinese population: A comprehensive genomic analysis. | Transl Oncol | 2025 | 40184718 | PubTator, text mining | PubMed |
| High-intensity interval training alleviates STZ-induced muscle atrophy by restoration of nuclear positioning defects in C57BL/6 male mice. | Sci Rep | 2025 | 40011606 | PubTator, text mining | PubMed |
| Clinical, Morphologic, and Genomic Findings in Spitz Tumors With RET Fusion: A Series of 31 Cases. | Mod Pathol | 2025 | 39986469 | PubTator, text mining | PubMed |
| Active microtubule-actin cross-talk mediated by a nesprin-2G-kinesin complex. | Sci Adv | 2025 | 39982998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=4